← Leaderboards
Qiming Jane Wang
University Of Pittsburgh At Pittsburgh
$6,348,050
Attributed
$6,348,050
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $618.2K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,348,050 · 6
By mechanism
R01$5,898,050 · 4
R21$425,000 · 1
R03$25,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Shivendra Singh$26,555,479
- Donald L Trump$24,661,732
- Dana P Ascherman$3,212,537
- Joseph C. Glorioso$19,383,290
- Beth R Pflug$937,744
Others in their field
Top investigators on “Family”
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$221,216,149
- David R. Weir · University Of Michigan At Ann Arbor$166,939,143
- Richard A Gibbs · Baylor College Of Medicine$137,231,081
- Sharon A Nachman · Johns Hopkins University$135,132,510
- George R Seage · Abt Associates, Inc.$128,485,281
Research focus
FamilySignal TransductionResponseIn VivoBaseProtein Kinase DTherapeutic TargetPhosphotransferasesMalignant NeoplasmsProstatic NeoplasmsTumor XenograftInsightMalignant Neoplasm Of ProstateCellsMigrationProtein IsoformsMediatingSignal PathwayPathogenesisMouse ModelPathway InteractionsDiglycerides1,2-DiacylglycerolCell Proliferation
Grant awards (23)
A novel mitotic regulatory axis in neuroendocrine prostate cancer$351,313
R01 · FY2023 · CA · contact PI
A novel mitotic regulatory axis in neuroendocrine prostate cancer$351,313
R01 · FY2022 · CA · contact PI
A novel mitotic regulatory axis in neuroendocrine prostate cancer$358,483
R01 · FY2021 · CA · contact PI
A novel mitotic regulatory axis in neuroendocrine prostate cancer$361,608
R01 · FY2020 · CA · contact PI
A novel mitotic regulatory axis in neuroendocrine prostate cancer$368,279
R01 · FY2019 · CA · contact PI
Novel long non-coding RNAs in neuronal survival in focal cerebral ischemia$232,500
R21 · FY2017 · NS · contact PI
Novel long non-coding RNAs in neuronal survival in focal cerebral ischemia$192,500
R21 · FY2016 · NS · contact PI
Development of small molecule inhibitors of protein kinase D$290,827
R01 · FY2014 · CA · contact PI
The role of PKD3 in prostate carcinogenesis$286,637
R01 · FY2013 · CA · contact PI
Development of small molecule inhibitors of protein kinase D$281,832
R01 · FY2013 · CA · contact PI
The role of PKD3 in prostate carcinogenesis$304,932
R01 · FY2012 · CA · contact PI
Development of small molecule inhibitors of protein kinase D$299,821
R01 · FY2012 · CA · contact PI
The role of PKD3 in prostate carcinogenesis$304,932
R01 · FY2011 · CA · contact PI
Development of small molecule inhibitors of protein kinase D$294,711
R01 · FY2011 · CA · contact PI
The role of PKD3 in prostate carcinogenesis$314,363
R01 · FY2010 · CA · contact PI
Development of small molecule inhibitors of protein kinase D$303,826
R01 · FY2010 · CA · contact PI
The role of PKD3 in prostate carcinogenesis$314,363
R01 · FY2009 · CA · contact PI
Protein kinase Dnu in regulated GLUT4 trafficking$212,504
R01 · FY2008 · DK · contact PI
Protein kinase Dnu in regulated GLUT4 trafficking$216,840
R01 · FY2007 · DK · contact PI
IMAP-Based Fluorescent Polarization Assay for HTS Protein Kinase D Inhibitors$25,000
R03 · FY2007 · DA · contact PI
protein kinase Dnu in regulated GLUT4 trafficking$223,316
R01 · FY2006 · DK · contact PI
protein kinase Dnu in regulated GLUT4 trafficking$228,690
R01 · FY2005 · DK
Protein kinase Dnu in regulated GLUT4 trafficking$229,460
R01 · FY2004 · DK